Omega Pharma sells 24.04% interest in Arseus for between 8.00 euro
and a maximum of 10.75 euro per s
(Thomson Reuters ONE) - WATERLAND BECOMES REFERENCE SHAREHOLDER IN ARSEUSWaregem (Belgium), 9 November 2009 (07:30 CET) - Omega Pharma NV,Arseus NV and Waterland Private Equity Investments ('Waterland')jointly announce today that Waterland has signed agreements topurchase a minority 25.10% interest in Arseus. Via its fourth fund,Waterland will purchase 7,500,000 shares (24.04%) from Omega Pharmaand 330,000 shares (1.06%) from Couckinvest NV at 8.00 euro perArseus share, plus an earn-out of up to 2.75 euro per share, payablewhen Waterland exits, depending on the future shareholder valuecreated by Arseus. Completion of the transaction is scheduled for25 November 2009.Arseus, the former Professional Health Division of Omega Pharma,became an independent entity on 5 October 2007 via an IPO. After theIPO, Omega Pharma held 7,500,000 Arseus shares or 24.04% of the totalshares in issue.Based on the denominator of 31,195,121 (total number of shares) andthe relevant notifications received by Arseus, the shareholdingstructure after completion of the transaction will be as follows:+-------------------------------------------------------------------+| Arseus | Number of shares | Percentage of total ||--------------------------+------------------+---------------------|| Waterland Private Equity | 7,830,000 | 25.10% || Fund IV CV | | ||--------------------------+------------------+---------------------|| Couckinvest NV / Coucke | 3,528,080 | 11.31% ||--------------------------+------------------+---------------------|| Fortis Investment | 2,756,357 | 8.84% || Management SA | | ||--------------------------+------------------+---------------------|| Arseus NV (treasury | 973,915 | 3.12% || shares) | | ||--------------------------+------------------+---------------------|| Public | 16,106,769 | 51.63% |+-------------------------------------------------------------------+Please open the link below for the full press release:http://hugin.info/138311/R/1353496/327854.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 09.11.2009 - 07:31 Uhr
Sprache: Deutsch
News-ID 8087
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 224 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Omega Pharma sells 24.04% interest in Arseus for between 8.00 euro
and a maximum of 10.75 euro per s"
steht unter der journalistisch-redaktionellen Verantwortung von
Arseus (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
